ENO2 and small cell carcinoma: Neuron-specific enolase (NSE)—one type of neuroendocrine enzyme—can serve as the assumed serum marker of small cell cancer and exhibits a remarkably diagnostic specificity and sensitivity [3,4,5,6,7,8,9].